Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

OBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis o...

Full description

Bibliographic Details
Main Authors:	Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
by: Mukhtyar, C, et al.
Published: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
by: Mukhtyar, C, et al.
Published: (2008)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
by: Flossmann, O, et al.
Published: (2006)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
by: Mukhtyar, C, et al.
Published: (2008)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
by: Robson, J, et al.
Published: (2017)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
by: Morishita, K, et al.
Published: (2017)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
by: Robson, J, et al.
Published: (2013)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
by: De Groot, K, et al.
Published: (2005)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
by: Noah Huizenga, et al.
Published: (2020-04-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
by: Weiran Li, et al.
Published: (2021-03-01)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
by: Rajaie Namas, et al.
Published: (2023-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
by: Sourabh Chand, et al.
Published: (2013-01-01)

Leg muscle strength is reduced and is associated with physical quality of life in Antineutrophil cytoplasmic antibody-associated vasculitis.
by: Arno C Hessels, et al.
Published: (2019-01-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
by: Talks, S, et al.
Published: (1994)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
by: Zdenka Hruskova, et al.
Published: (2020-02-01)

Antineutrophil cytoplasmic antibody vasculitis causing skull base inflammation and aortitis
by: Boby Varkey Maramattom, et al.
Published: (2018-01-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
by: Jamie R. Felzer, et al.
Published: (2022-01-01)

Antineutrophil cytoplasmic antibodies
by: G.D. Sebastiani
Published: (2011-06-01)

Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials
by: Walsh, M, et al.
Published: (2009)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
by: de Groot, K, et al.
Published: (2009)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
by: Chand, S, et al.
Published: (2013)

Frailty and antineutrophil cytoplasmic antibody‐associated vasculitis: What do we know?
by: Henry H. L. Wu, et al.
Published: (2023-12-01)

Acute respiratory failure as primary manifestation of antineutrophil cytoplasmic antibodies-associated vasculitis
by: Evdokia Sourla, et al.
Published: (2014-07-01)

Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
by: Jung Yoon Pyo, et al.
Published: (2022-12-01)

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology
by: Tessa K. Novick, et al.
Published: (2018-05-01)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
by: Albert Hing Wong, et al.
Published: (2022-06-01)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
by: Arman F, et al.
Published: (2018-11-01)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Zhi-Ying Li, et al.
Published: (2020-08-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in diffuse large B cell lymphoma
by: Taro Horino, et al.
Published: (2021-03-01)

Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Yuqi Zhang, et al.
Published: (2021-10-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
by: Moog P, et al.
Published: (2015-11-01)

Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab
by: Carmen Martín Varas, et al.
Published: (2017-09-01)

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
by: Jayne, DR, et al.
Published: (1997)

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
by: Taejun Yoon, et al.
Published: (2020-04-01)

Complement blockade in the management of antineutrophil cytoplasmic antibodyassociated vasculitis
by: JosÃ© Salvador GarcÃa-Morillo, et al.
Published: (2022-10-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in presence of positive antiphospholipid antibody: a case report
by: Maassoumeh Akhlaghi Kalahroodi, et al.
Published: (2022-01-01)

Comprehensive analysis of ferroptosis patterns and immunologic characteristics in antineutrophil cytoplasmic antibody-associated vasculitis
by: Mi Tao, et al.
Published: (2023-11-01)